Data search


search
Exact
Search

Results for MligTC455_47031

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_47031 2528 52.67 Mlig455_061589

Neo: -

Age: -

Mlig455_061589 {REF} {Length: 1260} {TRANSSPLICED} {RNA1509_11851, RNA1509_54469} {RNA1310_25201.1, RNA1509_11851, RNA1509_54469} {RNA1509_11851, RNA1509_54469, RNA815_11212.1}

Cumulative graph for MligTC455_47031

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.152 5.901 0.02656 0.42780
RegionR2 -0.542 5.901 0.41867 0.81054
RegionR3 0.382 5.901 0.48992 0.98867
RegionR4 0.062 5.901 0.92141 1.00000
RegionR5 0.515 5.901 0.33581 0.68181
RegionR6 0.609 5.901 0.26214 0.85011
RegionR7 0.842 5.901 0.10373 0.61277
RegionR8 0.284 5.901 0.62330 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -1.021 5.901 0.43025 1.00000
RegenerationR2 -0.003 5.901 0.99680 1.00000
RegenerationR3 -0.239 5.901 0.73713 0.95967
RegenerationR4 -0.091 5.901 0.90289 1.00000
RegenerationR5 -0.622 5.901 0.39035 0.79263
RegenerationR6 -0.5 5.901 0.49024 0.79914
RegenerationBL -0.848 5.901 0.19446 0.53042
RegenerationTP -0.584 5.901 0.39722 0.82716


Genes with expression patterns similar to MligTC455_47031

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_47031 2528 52.67 Mlig455_061589

Neo: -

Age: -

6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_061589 {REF} {Length: 1260} {TRANSSPLICED} {RNA1509_11851, RNA1509_54469} {RNA1310_25201.1, RNA1509_11851, RNA1509_54469} {RNA1509_11851, RNA1509_54469, RNA815_11212.1}
2. MligTC455_43576 2054 42.79 Mlig455_063200

Neo: -

Age: Down-Up-Up

AL031281.2 1.873 - - - 0.956 0.917 - Mlig455_063200 {REF} {Length: 2790} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=184.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=66.1]; ADP-ribosylation factor family [PF00025.23, score=27.8]; Elongation factor Tu GTP binding domain [PF00009.29, score=21.1]} {Human: ENSG00000285721, AL031281.2, novel protein, identical to cell division cycle 42 (GTP binding protein, 25kDa) CDC42, [RH, Score=335, Expect=2e-118]; ENSG00000070831, CDC42, cell division cycle 42, [RH, Score=335, Expect=2e-118]} {Mouse: ENSMUSG00000006699, Cdc42, cell division cycle 42, [RH, Score=335, Expect=1e-118]} {Dmel: FBgn0010341, Cdc42, [RH, Score=337, Expect=2e-119]} {Celegans: WBGene00000390, cdc-42, Cell division control protein 42 homolog, [RH, Score=326, Expect=2e-115]} {Smed: dd_Smed_v6_698_0_1, dd_Smed_v6_698_0_1, [RH, Score=325, Expect=6e-115]} {RNA1509_12280, RNA1509_33799, RNA1509_4460, RNA1509_47178} {RNA1310_22711, RNA1509_12280, RNA1509_33799, RNA1509_4460, RNA1509_47178} {RNA1509_12280, RNA1509_33799, RNA1509_4460, RNA1509_47178, RNA815_7681.1}
3. MligTC455_31410 10095 210.3 Mlig455_002152

Neo: Int S/G2/M

Age: -

1.704 - - - 0.744 0.960 - Mlig455_002152 {REF} {Length: 90} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_2901} {RNA815_21935}
4. MligTC455_39980 1112 23.17 Mlig455_019252, Mlig455_035527

Neo: -

Age: logFC(26M/2M)=0.336

GNPAT 0.968 - - - - 0.968 -

Mlig455_019252 {REF} {Length: 1935} {Pfam: Glycerol-3-phosphate acyltransferase C-terminal region [PF19277.1, score=73.1]} {Human: ENSG00000116906, GNPAT, glyceronephosphate O-acyltransferase, [Score=153, Expect=4e-40]} {Mouse: ENSMUSG00000031985, Gnpat, glyceronephosphate O-acyltransferase, [Score=147, Expect=3e-38]} {Dmel: FBgn0040212, Dhap-at, Dihydroxyacetone phosphate acyltransferase, [Score=112, Expect=2e-26]} {Celegans: WBGene00012911, acl-7, ACyLtransferase-like; Dihydroxyacetone phosphate acyltransferase, [Score=110, Expect=4e-26]} {Smed: dd_Smed_v6_8423_0_1, dd_Smed_v6_8423_0_1, [Score=128, Expect=5e-32]} {RNA1509_54841, RNA1509_9818} {RNA1310_4562.1, RNA1509_54841, RNA1509_9818} {RNA1509_54841, RNA1509_9818, RNA815_2294.1}

Mlig455_035527 {REF} {Length: 1784} {Pfam: Glycerol-3-phosphate acyltransferase C-terminal region [PF19277.1, score=72.9]} {Human: ENSG00000116906, GNPAT, glyceronephosphate O-acyltransferase, [Score=153, Expect=3e-40]} {Mouse: ENSMUSG00000031985, Gnpat, glyceronephosphate O-acyltransferase, [Score=147, Expect=3e-38]} {Dmel: FBgn0040212, Dhap-at, Dihydroxyacetone phosphate acyltransferase, [Score=112, Expect=3e-26]} {Celegans: WBGene00012911, acl-7, ACyLtransferase-like; Dihydroxyacetone phosphate acyltransferase, [Score=110, Expect=8e-26]} {Smed: dd_Smed_v6_8423_0_1, dd_Smed_v6_8423_0_1, [Score=129, Expect=2e-32]} {RNA1509_54841} {RNA1310_4562.1} {RNA815_2294.1}
5. MligTC455_44350 945 19.69 Mlig455_063524

Neo: -

Age: -

RRAS2 0.967 - - - - 0.967 - Mlig455_063524 {REF} {Length: 3161} {Pfam: Ras family [PF00071.24, score=162.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=67.9]; ADP-ribosylation factor family [PF00025.23, score=40.8]; Elongation factor Tu GTP binding domain [PF00009.29, score=26.9]; 50S ribosome-binding GTPase [PF01926.25, score=19.0]; Signal recognition particle receptor beta subunit [PF09439.12, score=19.0]} {Human: ENSG00000133818, RRAS2, RAS related 2, [RH, Score=179, Expect=7e-57]; ENSG00000126458, RRAS, RAS related, [RH, Score=173, Expect=3e-54]} {Mouse: ENSMUSG00000055723, Rras2, related RAS viral (r-ras) oncogene 2, [RH, Score=179, Expect=5e-57]; ENSMUSG00000038387, Rras, related RAS viral (r-ras) oncogene, [RH, Score=172, Expect=5e-54]} {Dmel: FBgn0003206, Ras64B, Ras oncogene at 64B, [RH, Score=166, Expect=5e-52]} {Celegans: WBGene00004310, ras-1, GTP binding protein; R-RAS related; R-ras1 homolog, [RH, Score=181, Expect=1e-57]} {Smed: dd_Smed_v6_1239_0_1, dd_Smed_v6_1239_0_1, [Score=168, Expect=3e-53]} {RNA1509_26364, RNA1509_27424, RNA1509_8658} {RNA1310_4951.1, RNA1509_26364, RNA1509_27424, RNA1509_8658} {RNA1509_26364, RNA1509_27424, RNA1509_8658, RNA815_12694.1}
6. MligTC455_33340 730 15.2 Mlig455_032566, Mlig455_032634

Neo: -

Age: -

CBL 0.965 - - - 0.965 - -

Mlig455_032566 {REF} {Length: 2571} {TRANSSPLICED} {Pfam: CBL proto-oncogene N-terminus, EF hand-like domain [PF02761.16, score=106.3]; CBL proto-oncogene N-terminus, SH2-like domain [PF02762.16, score=92.4]; CBL proto-oncogene N-terminal domain 1 [PF02262.18, score=72.7]; Prokaryotic RING finger family 4 [PF14447.8, score=49.7]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=42.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=29.7]; Ring finger domain [PF13639.8, score=28.3]; RING-type zinc-finger [PF13445.8, score=25.7]; zinc-RING finger domain [PF14634.8, score=20.4]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=18.7]} {Human: ENSG00000110395, CBL, Cbl proto-oncogene, [Score=342, Expect=9e-108]; ENSG00000114423, CBLB, Cbl proto-oncogene B, [Score=337, Expect=1e-105]} {Mouse: ENSMUSG00000034342, Cbl, Casitas B-lineage lymphoma, [Score=344, Expect=1e-108]; ENSMUSG00000022637, Cblb, Casitas B-lineage lymphoma b, [Score=337, Expect=2e-105]} {Dmel: FBgn0020224, Cbl, Cbl proto-oncogene, [Score=325, Expect=3e-106]} {Celegans: WBGene00004829, sli-1, Sli-1 protein; Suppressor of LIneage defect, [Score=291, Expect=3e-92]} {Smed: dd_Smed_v6_6780_0_1, dd_Smed_v6_6780_0_1, [Score=281, Expect=4e-88]} {RNA1509_34426} {RNA1310_7631.1} {RNA815_3518}

Mlig455_032634 {REF} {Length: 2573} {TRANSSPLICED} {Pfam: CBL proto-oncogene N-terminus, EF hand-like domain [PF02761.16, score=106.4]; CBL proto-oncogene N-terminus, SH2-like domain [PF02762.16, score=92.4]; CBL proto-oncogene N-terminal domain 1 [PF02262.18, score=72.7]; Prokaryotic RING finger family 4 [PF14447.8, score=49.7]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=42.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=29.8]; Ring finger domain [PF13639.8, score=28.3]; RING-type zinc-finger [PF13445.8, score=25.7]; zinc-RING finger domain [PF14634.8, score=20.4]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=18.7]} {Human: ENSG00000110395, CBL, Cbl proto-oncogene, [Score=342, Expect=1e-107]; ENSG00000114423, CBLB, Cbl proto-oncogene B, [Score=336, Expect=2e-105]} {Mouse: ENSMUSG00000034342, Cbl, Casitas B-lineage lymphoma, [Score=344, Expect=2e-108]; ENSMUSG00000022637, Cblb, Casitas B-lineage lymphoma b, [Score=337, Expect=3e-105]} {Dmel: FBgn0020224, Cbl, Cbl proto-oncogene, [Score=325, Expect=4e-106]} {Celegans: WBGene00004829, sli-1, Sli-1 protein; Suppressor of LIneage defect, [Score=290, Expect=5e-92]} {Smed: dd_Smed_v6_6780_0_1, dd_Smed_v6_6780_0_1, [Score=281, Expect=5e-88]} {RNA1509_34426} {RNA1310_7631.1} {RNA815_3518}
7. MligTC455_48287 637 13.27 Mlig455_025930

Neo: Int S/G2/M

Age: Down-Up-Up

Region-enriched R5: 2.867/0.00000

0.958 - - - 0.958 - - Mlig455_025930 {REF} {Length: 990} {TRANSSPLICED} {RNA1509_54367} {RNA1310_36589.1} {RNA815_54285}
8. MligTC455_21842 17243 359.23 Mlig455_007586, Mlig455_036063

Neo: Int S/G2/M

Age: Down-Down-Up, logFC(26M/2M)=0.653

Region-enriched R4: 1.020/0.00071

RPL27A 0.956 - - - - 0.956 -

Mlig455_007586 {REF} {Length: 605} {TRANSSPLICED} {Pfam: Ribosomal proteins 50S-L15, 50S-L18e, 60S-L27A [PF00828.21, score=65.4]} {Human: ENSG00000166441, RPL27A, ribosomal protein L27a, [RH, Score=224, Expect=4e-76]} {Mouse: ENSMUSG00000046364, Rpl27a, ribosomal protein L27A, [RH, Score=224, Expect=4e-76]} {Dmel: FBgn0285948, RpL27A, Ribosomal protein L27A, [RH, Score=208, Expect=3e-70]} {Celegans: WBGene00021350, Y37E3.8, [RH, Score=212, Expect=7e-72]} {Smed: dd_Smed_v6_155_1_1, dd_Smed_v6_155_1_1, [RH, Score=242, Expect=1e-83]} {RNA1509_6380} {RNA1310_59978} {RNA815_11321.1}

Mlig455_036063 {REF} {Length: 605} {TRANSSPLICED} {Pfam: Ribosomal proteins 50S-L15, 50S-L18e, 60S-L27A [PF00828.21, score=65.4]} {Human: ENSG00000166441, RPL27A, ribosomal protein L27a, [RH, Score=224, Expect=4e-76]} {Mouse: ENSMUSG00000046364, Rpl27a, ribosomal protein L27A, [RH, Score=224, Expect=4e-76]} {Dmel: FBgn0285948, RpL27A, Ribosomal protein L27A, [RH, Score=208, Expect=3e-70]} {Celegans: WBGene00021350, Y37E3.8, [RH, Score=212, Expect=7e-72]} {Smed: dd_Smed_v6_155_1_1, dd_Smed_v6_155_1_1, [RH, Score=242, Expect=1e-83]} {RNA1509_6380} {RNA1310_59978, RNA1509_6380} {RNA1509_6380, RNA815_11321.1}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA